Wilma Pastori

715 total citations
14 papers, 201 citations indexed

About

Wilma Pastori is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Wilma Pastori has authored 14 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Wilma Pastori's work include Quinazolinone synthesis and applications (3 papers), Cancer-related Molecular Pathways (3 papers) and Neuroblastoma Research and Treatments (2 papers). Wilma Pastori is often cited by papers focused on Quinazolinone synthesis and applications (3 papers), Cancer-related Molecular Pathways (3 papers) and Neuroblastoma Research and Treatments (2 papers). Wilma Pastori collaborates with scholars based in Italy, United States and Switzerland. Wilma Pastori's co-authors include Marina Ciomei, Mariangela Mariani, Maria Grandi, Nicola Mongelli, Francesco Sola, Dario Ballinari, Arturo Galvani, Ciro Mercurio, Clara Albanese and Francesco Fiorentini and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and British Journal of Pharmacology.

In The Last Decade

Wilma Pastori

14 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wilma Pastori Italy	7	116	75	51	39	35	14	201
Denise L. Driscoll United States	6	142 1.2×	46 0.6×	78 1.5×	26 0.7×	34 1.0×	7	236
Sachie Otsuki Japan	5	143 1.2×	76 1.0×	50 1.0×	28 0.7×	17 0.5×	5	233
Yuzhu Cheng United Kingdom	8	165 1.4×	76 1.0×	47 0.9×	33 0.8×	36 1.0×	9	253
Hirokazu Ohsawa Japan	7	192 1.7×	120 1.6×	29 0.6×	90 2.3×	13 0.4×	11	334
Dirk Kosemund Germany	3	107 0.9×	80 1.1×	29 0.6×	30 0.8×	51 1.5×	3	164
Kwong-Him To Canada	2	177 1.5×	170 2.3×	22 0.4×	38 1.0×	17 0.5×	2	261
Simon Bayle United States	5	173 1.5×	120 1.6×	18 0.4×	64 1.6×	18 0.5×	10	251
Emma J. Haagensen United Kingdom	8	216 1.9×	91 1.2×	12 0.2×	43 1.1×	41 1.2×	11	280
Marty J. Heslin United States	5	245 2.1×	104 1.4×	33 0.6×	20 0.5×	15 0.4×	7	329
Bo Kyung A. Seong United States	7	259 2.2×	89 1.2×	17 0.3×	41 1.1×	23 0.7×	7	331

Countries citing papers authored by Wilma Pastori

Since Specialization

Citations

This map shows the geographic impact of Wilma Pastori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilma Pastori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilma Pastori more than expected).

Fields of papers citing papers by Wilma Pastori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilma Pastori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilma Pastori. The network helps show where Wilma Pastori may publish in the future.

Co-authorship network of co-authors of Wilma Pastori

This figure shows the co-authorship network connecting the top 25 collaborators of Wilma Pastori. A scholar is included among the top collaborators of Wilma Pastori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilma Pastori. Wilma Pastori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ardini, Elena, Andrea Borgia, Gemma Texidó, et al.. (2016). NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding activity on gatekeeper resistance mutations, high tolerability, and potential for combination therapies. European Journal of Cancer. 69. S127–S128. 1 indexed citations

Pulici, Maurizio, Gabriella Traquandi, Chiara Marchionni, et al.. (2014). Optimization of Diarylthiazole B‐Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical Effect. ChemMedChem. 10(2). 276–295. 9 indexed citations

Banfi, Patrizia, Fabio Gasparri, R. M. Borzilleri, et al.. (2014). Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers. Experimental Cell Research. 332(2). 267–277. 27 indexed citations

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2013). Anti‐tumour efficacy on glioma models of PHA‐848125, a multi‐kinase inhibitor able to cross the blood–brain barrier. British Journal of Pharmacology. 169(1). 156–166. 18 indexed citations

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2010). Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. Molecular Cancer Therapeutics. 9(8). 2243–2254. 51 indexed citations

Traquandi, Gabriella, Marina Ciomei, Dario Ballinari, et al.. (2010). Identification of Potent Pyrazolo[4,3-h]quinazoline-3-carboxamides as Multi-Cyclin-Dependent Kinase Inhibitors. Journal of Medicinal Chemistry. 53(5). 2171–2187. 35 indexed citations

Alzani, Rachele, Clara Albanese, Giuseppe Locatelli, et al.. (2008). 294 POSTER Biological characterization of the dual CDK2/TRKA inhibitor PHA-848125. European Journal of Cancer Supplements. 6(12). 94–95. 1 indexed citations

Mercurio, Ciro, Wilma Pastori, Rachele Alzani, et al.. (2004). In vitro and in vivo characterization of the CDK2 inhibitor PHA-533533. 64. 190–190. 2 indexed citations

Ciomei, Marina, et al.. (1995). Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine). British Journal of Cancer. 72(6). 1504–1508. 5 indexed citations

10.

Ciomei, Marina, Wilma Pastori, Mariangela Mariani, et al.. (1994). New sulfonated distamycin a derivatives with bFGF complexing activity. Biochemical Pharmacology. 47(2). 295–302. 40 indexed citations

11.

Ciomei, Marina, et al.. (1993). In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.. PubMed. 13(1). 75–9. 2 indexed citations

12.

Mariani, Mariangela, Alfredo Paio, Marina Ciomei, et al.. (1992). In vitro activity of novel sulphonic derivatives of distamicyn A. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 61. 455–458. 7 indexed citations

13.

Ciomei, Marina, Wilma Pastori, & Fernando C. Giuliani. (1986). The Influence of Amphotericin B on Differentiation Induced by Dimethylsulfoxide and Actinomycin D in HL60 and Friend Cell Lines. Tumori Journal. 72(6). 545–551. 1 indexed citations

14.

Marco, Aurelio Di, Teresa Dasdia, & Wilma Pastori. (1984). Interaction of Calcium Ions and Camp on the Cytotoxic Effect of Doxorubicin. Tumori Journal. 70(3). 217–221. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact